Our guide to semiconductor companies and how their chips run our everyday lives

Our guide to semiconductor companies and how their chips run our everyday lives


The logo of Nvidia Corporation is seen during the annual Computex computer exhibition in Taipei, Taiwan May 30, 2017. 

Tyrone Siu | Reuters

The semiconductor, or chip, industry is perhaps one of the most important and complex sectors in the stock market to understand. Chips are in everything from our smartphones to cars and to all facets of computing, from PCs to massive data centers used for the cloud. Put simply, they are the bricks and mortar of the digital world. We don’t see them, but we know they magically make stuff work.



Source

Stellantis stock off 43% as Jeep maker turns five, executes turnaround
Business

Stellantis stock off 43% as Jeep maker turns five, executes turnaround

Stellantis North America COO and Jeep CEO Antonio Filosa speaks during the Stellantis press conference at the Automobility LA 2024 car show at Los Angeles Convention Center in Los Angeles, California, November 21, 2024. Etienne Laurent | AFP | Getty Images DETROIT — Five years after the transatlantic automaker Stellantis was formed through a merger, […]

Read More
Disney dominated the 2025 box office. Here’s how it could keep the crown in 2026
Business

Disney dominated the 2025 box office. Here’s how it could keep the crown in 2026

Courtesy of Disney Enterprises Inc. Blue aliens, a family of superheroes and a city of talking animals boosted the Walt Disney Company to the top of the domestic box office in 2025. Full-year ticket sales in the United States and Canada rose about 4% from 2024 to $9.05 billion. Disney accounted for the highest share […]

Read More
Novo Nordisk shares rise 5% after Wegovy obesity pill has ‘solid’ launch
Business

Novo Nordisk shares rise 5% after Wegovy obesity pill has ‘solid’ launch

A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, US, on Thursday, Jan. 15, 2026. George Frey | Bloomberg | Getty Images Shares of Novo Nordisk rose more than 5% on Friday after early prescription data showed an encouraging start to the U.S. launch of the company’s new GLP-1 pill […]

Read More